Which hospital has Mobosetinib and can patients buy it?

Mobocertinib is a targeted drug used as a second-line drug to treat locally advanced or metastatic non-small cell lung cancer (mNSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations. In clinical studies, this treatment produced responses in some patients, nearly28% of patients had a partial response (tumor shrinkage) to mobosetinib treatment, with a duration of response (DoR) lasting approximately 17.5 months. Mobocertinib is classified as an oral kinase inhibitor. Kinases are enzymes that affect different cellular functions and may promote growth. This is the first oral therapy specifically designed to target EGFR exon 20 insertion mutations. Mobosetinibinhibits (blocks) and irreversibly bindsEGFR exon 20 insertion mutations to slow lung cancer growth.

MobosetinibThe original drug is currently on the market in China and has not yet been included in medical insurance. SpecificationsThe price of 40mg*112 capsules per box is around 40,000 yuan, which is very expensive. This drug may be sold in domestic hospitals and other places, but Patients need to choose drug treatment based on the doctor's prescription informationThe Hong Kong version of the original drug Specifications 40mg*30 capsules per box is priced at more than RMB 7,000 (the price may fluctuate due to exchange rates). Generic drugs of Mobotinib have also been put on the market for sale overseas. The drug ingredients are basically the same as those of the original drugs at home and abroad. For example, the production specifications of Laos Pharmaceutical Factory40mg*120 pills per boxThe pricemay be more than 4,000 yuan (the price may fluctuate due to the exchange rate), and the price is relatively cheap. For specific prices and drug information of overseas drugs, please consult Yaode Medical Consultant.